Company profile
Fuse Medical, Inc.
OTC: FZMD · Healthcare · Medical - Devices
#559 of 1,418 Healthcare companies by revenue33rd-percentile growth
EA Score
——FH —DQ 38GM —SS 55
v0.1 · 25/100 weight · pillars only
↑ return on assets, growth stability · ↓ filing timeliness, balance-sheet leverage
Methodology →Revenue TTM
$18.4M
Rev growth YoY (TTM)
-5.8%
Net income (FY)
$3.1M
Employees
31
as of 2026-08-25
Market cap
$1.5M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$18.6M$18.6M2022
Net income$3.1M$3.1M2022
Operating income-$815.1k-$815.1k2022
Total assets$19.8M$19.8M2022
Liabilities$20.1M$20.1M2022
Equity-$310.9k-$310.9k2022
Revenue trend
FY2015 – FY2022 · USD
FY15
FY17
FY17
FY19
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Fuse Medical, Inc.’s revenue?
Fuse Medical, Inc. booked $18.6M in FY2022 revenue, contracting 8.7% year over year — slower than 67% of Healthcare companies we track, at a 16.6% net margin.
Peers · Healthcare
Aurora Spine Corporation65BRennova Health, Inc.——OmniAb, Inc.50DPD-Rx Pharmaceuticals, Inc.70BAvicanna Inc.55CTrees Corporation——Neighbors
Dallas →Key facts
CEOChristopher C. Reeg
SectorHealthcare
IndustryMedical - Devices
HeadquartersRichardson, TX
ExchangeOTC: FZMD
Employees31
IPO date1999-05-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.